Sumitovant is a wholly-owned subsidiary of Sumitomo Dainippon and operates out of offices in New York and London. Sumitovant is the parent company of five biopharma companies: Urovant, Enzyvant, Altavant and Spirovant and is the majority owner of Myovant, a publicly listed life sciences company.
Is Roivant Sciences public company?
Type Public
--------- ---------------
Traded as Nasdaq: ROIV
Industry Pharmaceuticals
Founded 2014
Founder Vivek Ramaswamy